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Noggin inactivation affects the 
number and differentiation 
potential of muscle progenitor cells 
in vivo
Domiziana Costamagna1,2,*, Hendrik Mommaerts3,*, Maurilio Sampaolesi1,4 & 
Przemko Tylzanowski3,5
Inactivation of Noggin, a secreted antagonist of Bone Morphogenetic Proteins (BMPs), in mice leads, 
among others, to severe malformations of the appendicular skeleton and defective skeletal muscle 
fibers. To determine the molecular basis of the phenotype, we carried out a histomorphological and 
molecular analysis of developing muscles Noggin−/− mice. We show that in 18.5 dpc embryos there is 
a marked reduction in muscle fiber size and a failure of nuclei migration towards the cell membrane. 
Molecularly, the absence of Noggin results in an increased BMP signaling in muscle tissue as shown 
by the increase in SMAD1/5/8 phosphorylation, concomitant with the induction of BMP target genes 
such as Id1, 2, 3 as well as Msx1. Finally, upon removal of Noggin, the number of mesenchymal Pax7+ 
muscle precursor cells is reduced and they are more prone to differentiate into adipocytes in vitro. Thus, 
our results highlight the importance of Noggin/BMP balance for myogenic commitment of early fetal 
progenitor cells.
Noggin is a glycosylated, secreted 64 kDa protein homodimer and one of the many extracellular antagonists of 
the Bone Morphogenetic Protein (BMP) signaling pathway. Similar to Chordin, Chordin-like, Follistatin, Fsrp 
and Cerberus, Noggin encodes a protein that directly binds to the BMP (BMP2, BMP4, BMP5, BMP7) or Growth 
Differentiation Factor (GDF5, GDF6) ligands with various affinities1,2. By preventing interaction of the ligands 
with their receptor, Noggin interferes with the downstream activation of the signaling cascade.
Loss of Noggin in mice resulted in an embryonic lethal phenotype that is characterized by different develop-
mental defects such as exencephaly, axial outgrowth defects with a loss of the caudal vertebrae, failure of neural 
tube closure, excessive cartilage formation and fused joints to mention a few3,4.
During embryonic development, the bilaterally organized somites differentiate into a ventral-medial part, 
called the sclerotome, and a dorsal-lateral part, called the dermomyotome. The sclerotome gives rise to the carti-
lage and the bone of the vertebral column, while the dermomyotome develops into muscle, endothelia, cartilage, 
connective tissue and dermis.
At 9.5 dpc, delamination and migration of Pax3 positive (Pax3+) cells originating from the dermomyotome 
enables the differentiation of muscle progenitor cells in the myotome and in the limb. At 10.5–12.5 dpc, the first 
wave of myogenesis (embryonic myogenesis) takes place. Embryonic myoblasts fuse with each other and dif-
ferentiate into large primary myofibers5. As most of the myoblasts remain in a committed and undifferentiated 
state, the number of myofibers produced in this first wave is limited. These primary fibers serve to form the 
basic muscle pattern6. Another cell type, which is Pax7+, remains undifferentiated. These cells are present from 
early stages onwards and give rise to fetal myoblasts7. Their proliferation is triggered by mitogens secreted by the 
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primary fibers and they will differentiate into many smaller secondary myofibers during the secondary wave of 
myogenesis (14.5–16.5 dpc), or fetal myogenesis8.
Yet not all Pax7+ cells proliferate and differentiate but some remain in an undifferentiated state and become 
activated in the postnatal life following triggers like trauma or physical exercise. These cells are called satellite cells 
when they can be morphologically identified as mononucleated cells residing between the myofiber plasma mem-
brane and the basal lamina (from 17.5 dpc onwards). They are considered to form the stem cell niche responsible 
for the growth and restoration of the muscle9.
The dermomyotomal and sclerotomal somitic populations are subject to the intricate crosstalk of several sig-
naling cascades including WNT, Sonic hedgehog (SHH), and Bone Morphogenetic proteins (BMPs), ensuring a 
regulated differentiation of these lineages. WNT signaling from the overlying epidermis and the roof plate of the 
neural tube induces the expression of dermomyotome specific genes, while SHH signaling from the notochord 
and the floor plate of the neural tube induces sclerotomal gene expression10. In addition, BMP expression in the 
epidermis, the roof plate of the neural tube and the lateral plate mesoderm prevent the differentiation of myogenic 
lineage11. Differently, Noggin, present in the roof and floor plate of the neural tube, blocks this BMP action and 
therefore allows for the myogenic precursors to differentiate12,13. This balance between multiple signaling path-
ways results, among others, in the restricted expression of myogenic regulatory factors (MRF) and Pax genes in 
myogenic cell populations14.
Besides its role during the patterning of the somite, BMP signaling also affects the differentiation of myofibers. 
The effect of BMP signaling was shown to depend on the developmental stage and the progression along the myo-
genic program. Whereas the differentiation of embryonic myoblasts was shown to be insensitive to BMP signals, 
the fetal myoblasts and the Pax7+ precursors require a decrease of the BMP signaling in order to allow further 
myogenic differentiation8.
We have reported before that the Noggin null (Noggin−/−) mice presented a muscle defect during the final 
stages of in utero development4. From early stages onwards the size of the muscles was reduced. At 18.5 dpc, the 
Noggin−/− embryos displayed a dramatic muscle phenotype characterized by disorganized myofibers that failed 
to align. In addition, the number of multinucleated myofibers was reduced, more mononucleated myoblasts were 
found and the nuclei failed to migrate towards the plasma membrane in the Noggin−/− muscles. The defects 
appear late during the development since we could not detect them at 16.5 dpc, indicating that the phenotype was 
induced between 16.5 dpc and 18.5 dpc (fetal myogenesis). While we made that observation, the molecular basis 
of that phenotype was not investigated. Here we focused on the molecular mechanisms underlying the pheno-
type. Our results suggest that the absence of Noggin, and consequently BMP hypersignaling, leads to the decrease 
of the number of muscle progenitor cells and their phenotypic shift towards adipocytes in vitro.
Results
Noggin−/− muscle fibers display a reduced fiber thickness. The limb muscles of Noggin−/− mice are 
strongly affected, with some of them missing and others severely malformed. Thus, to carry out a meaningful 
phenotypic analysis that would focus on the primary molecular differences rather than consequences of severe 
muscle malformation, we needed to select anatomically the same muscle in both genotypes. We performed H&E 
staining and compared the forelimb anatomy using the Jatlasviewer (www.emouseatlas.org/emap/analysis_tools_
resources/software/jatlasviewer.html). We identified musculus flexor carpi ulnaris (indicated in red in Fig. 1A,B) 
as the muscle clearly identifiable and the least malformed in both wild type and Noggin null genotypes (Fig. 1C,E). 
For the analysis, we focused on three different developmental stages: one without an apparent defect (16.5 dpc), a 
dramatic defect (18.5 dpc) and the stage in between (17.5 dpc) (Fig. 1C–E’).
Since the histological appearance of the muscle suggested defective fiber thickness, we performed an F-Actin 
staining, using Phalloidin, and measured thickness of muscle fibers by measuring the muscle fiber diameter using 
ImageJ software. No difference in the overall morphology or in fiber thickness could be detected at 16.5 dpc in 
both genotypes. At 17.5 dpc Noggin−/− myofibers were slightly but significantly thinner and this trend persisted 
until 18.5 dpc where the difference was apparent (Fig. 1F–H’). Quantitative analysis of this observation confirmed 
the histological phenotype (Fig. 1I).
The loss of Noggin increases BMP signaling in embryonic muscles. Canonical BMP signaling phos-
phorylates SMAD1/5/8 and this phosphorylation status is used to detect active BMP signaling. Since Noggin is 
a BMP antagonist, its absence should result in augmented BMP signaling. Therefore we investigated the acti-
vation of the SMAD1/5/8 proteins. The immunohistochemical analysis for the phosphorylated SMAD1/5/8 
(P-SMAD1/5/8) displayed an increase in the number of positive cells in the muscle already from 16.5 dpc onwards 
as quantified in Fig. 2A and shown in Fig. 2B–C’. To confirm that observation we carried out Western Blot (WB) 
analysis for both P-SMAD1/5/8 and IDs proteins levels (Fig. 2D,E respectively) in the same muscle. The results of 
the P-SMAD1/5/8 WB has been quantified (Fig. 2F).
To verify the presence of active BMP signaling in the Noggin−/− musculus flexor carpi ulnaris, we investigated 
the expression of BMP immediate target genes. Using qRT-PCR at 16.5 dpc, we detected apparent upregulation of 
Msx2 and significant upregulation of Id3 and Msx1 (Fig. 2G).
Thus, at 16.5 dpc we detected the onset of molecular changes preceding the histological defects detectable 24 
hours later.
The loss of Noggin does not affect the rate of proliferation. One of the functions of BMP signaling is 
to promote the exit from the cell cycle15. Thus one might expect that in the absence of Noggin, the cellular prolif-
eration could be impaired leading to a decrease in the size of the muscle16. To address this issue, we analyzed the 
mitotic activity of the limb muscle cells using a KI67 antibody. KI67 is a nuclear protein present mainly in the G2, 
M, and at the end of the S phase and its presence is associated with active cell proliferation17. Despite the differences 
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Figure 1. Analysis of the muscle fiber thickness. (A,B) The limb at 15–16 dpc using Jatlasviewer. The 
musculus flexor carpi ulnaris is colored in red. (C–E’) H&E staining on sagittal sections of the limbs at the 
indicated stages and genotype. The musculus flexor carpi ulnaris is digitally indicated in green. (F–H’) Actin 
immunofluorescence on cross-sections of muscles at the indicated stages. (I) Quantification using ImageJ of the 
thickness of the fiber. Values plotted as mean ± sem; over 100 fibers of at least 3 different mice embryos were 
analyzed per condition; *p < 0.05
www.nature.com/scientificreports/
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in muscle size and fiber thickness, no significant difference in cell proliferation could be detected in Noggin−/− 
muscles between the 16.5 dpc (no observable muscle phenotype) and 18.5 dpc (a strong phenotype) (Fig. 3).
Noggin−/− muscles have less Pax7+ progenitor cells. The cell proliferation was not affected in the muscle 
of Noggin null mice and the onset of muscle phenotype was relatively late during embryogenesis. Thus we hypothe-
sized that perhaps not the muscle induction but rather muscle growth could be affected by excessive BMP signaling. 
During the muscle growth, Pax7+ cells provide the reservoir of stem cells that selectively enter myogenic 
Figure 2. Analysis of the BMP signaling pathway. (A) Quantification of P-SMAD1/5/8 immunohistochemistry 
on sagittal sections of musculus flexor carpi ulnaris of Noggin+/+ and Noggin−/− mice at the three different 
stages investigated. Values plotted as mean ± SEM; n = 5; *p < 0.05. Representative immunohistochemistry for 
P-SMAD1/5/8 at 16.5 dpc in Noggin+/+ (B) and Noggin−/− muscle (C). Enlargement of muscle area delineated in black 
in B’ and C’. Muscle is delineated in red, cartilage and bone in blue. Scale bar: 100 μ m. (D) WB analysis of the levels of 
P-SMAD1/5/8 compared to total SMAD1/5/8 and (E) IDs, normalized for GAPDH. (F) Quantification of the WB, 
data are representative of 3 independent experiments and values are expressed as mean ± sd; *p < 0.05, **p < 0.01.  
(G) qPCR analysis of BMP target genes at E16.5 dpc. Values plotted as mean ± SEM; n = 5; *p < 0.05.
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differentiation and contribute to the growth of the muscle fiber during late embryonic development and in post-
natal muscle repair processes18,19. Since BMP has a known negative effect on myogenesis (reviewed in ref. 20), 
we hypothesized that perhaps the number of Pax7+ cells in the late embryonic muscle could be reduced in the 
absence of Noggin. To investigate that, we carried out immunohistochemical analysis of the developing limb 
muscle for the expression of Pax7. Following the staining, we counted the number of positive cells using ImageJ 
software. Indeed, the number of Pax7+ cells was significantly reduced in Noggin−/− muscles throughout the stages 
investigated (Fig. 4).
Impairment of myogenic potential in Noggin null progenitors. The cell proliferation was not affected 
in Noggin−/− mice, but the number of Pax7+ progenitor cells was reduced. To exclude a defective proliferation, 
we analyzed the levels of P-ERK21,22. To accomplish that, fetal myoblast progenitors from Noggin−/− and wild type 
embryos were isolated from 16.5 dpc limbs and cultured under myogenic conditions. No significant differences 
Figure 3. Analysis of the mitotic activity. (A) Quantification of KI67 immunohistochemistry on sagittal 
sections of musculus flexor carpi ulnaris of Noggin+/+ and Noggin−/− mice at the three different stages 
investigated. Values plotted as mean ± SEM; n = 5; *p < 0.05. Representative immunohistochemistry for Ki67 
at 16.5 dpc in Noggin+/+ (B) and Noggin−/− (C) muscle. Muscle is delineated in red, cartilage and bone in blue. 
(B’–C’) Enlargement of muscle area delineated in black in B and C. Scale bar: 100 μ m.
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were detected in the levels of P-ERK, suggesting no defects in the proliferation rate were present in the muscle 
progenitors of Noggin−/− mice (Fig. 5A,B).
Next, to address the differentiation potential of progenitor cells, Noggin−/− cells were analyzed by qRT-PCR 
at 0 and 3 days of differentiation in vitro (Fig. 5C). At day 0, no significant differences in the expression levels of 
myogenic markers between Noggin+/+ and Noggin−/− cells were detected, with the exception of MyoD mRNA. 
After 3 days in culture, the expression of the myogenic progenitor markers, Pax3 and Pax7, decreased signifi-
cantly irrespective of the genetic background. The expression levels of myogenic markers like MyoD, Myf5 and 
Myogenin increased in the wild type while decreased significantly in the Noggin−/− mouse cells (Fig. 5C). Thus 
as expected23,24, under the in vitro differentiation conditions used, the Pax3+ and Pax7+ cells did not maintain 
growth. At the same time, in the absence of Noggin, myogenic differentiation was repressed.
To ensure that the analyzed cell population was free of other cells that might affect the outcome of the exper-
iment, we tested for the presence of cell types commonly contaminating such cultures, such as fibroblasts or 
chondrocytes. No large differences in the expression levels of Collagen II (Coll II) and SOX925 (Fig. 5D), Thy126 
and HSP4727 (Fig. 5E), PDGFRa28 (Fig. 5F) were detected in the mRNA extracted from Noggin+/+ and Noggin−/− 
cells, thus excluding any contamination of chondrocytes, fibroblasts or mesenchymal/endothelial stem cells 
respectively.
Figure 4. Analysis of the satellite cells. (A) Quantification of Pax7 immunohistochemistry on sagittal sections 
of musculus flexor carpi ulnaris of Noggin+/+ and Noggin−/− mice at the three different stages investigated. 
Values plotted as mean ± SEM; n≤ 5; *p < 0.05. Representative immunohistochemistry for Pax7 at 18 dpc 
in Noggin+/+ (B) and Noggin−/− (C) limbs. Muscle is delineated in red, cartilage and bone in blue. (B’-C’) 
Enlargement of muscle area delineated in black. Scale bar: 100 μ m.
www.nature.com/scientificreports/
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Loss of myogenic differentiation in Noggin−/− progenitor cells. Next, we analyzed the cellular distri-
bution of Pax7 and Myf5. Dual immunofluorescence revealed an apparent decrease in number of nuclei positive 
for Pax7 and Myf5 in Noggin−/− fetal myoblasts as compared to Noggin+/+. The percentage of Pax7+ and Myf5+ 
Figure 5. Myogenic differentiation of Noggin−/− early fetal progenitors. (A) WB analysis and (B) protein 
quantification for the expression levels of P-ERK normalized on the total protein content and GAPDH for 
Noggin−/− compared to Noggin+/+ 16.5 dpc muscle early fetal progenitors. (C) Expression levels of genes (Myf5, 
Pax3, Pax7, Id3, MyoD and Myogenin) involved in myogenesis at 0 and 3 days (d0, d3) of differentiation for 
Noggin+/+ and Noggin−/− cells. (D) Expression levels of chondrocytes (Coll II, Sox9), fibroblasts (Thy1, Hsp47) 
or mesenchymal stem cell (Pdgfra) in Noggin+/+ and Noggin−/− early fetal progenitor cells. Results are expressed 
as Δ Δ ct normalized to specific housekeeping genes (Gapdh, Hprt and Tbp). Data are representative of 3 
independent experiments and values are expressed as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001 Noggin+/+, 
$p < 0.05, $$p < 0.01, $$$p < 0.001 Noggin−/−.
www.nature.com/scientificreports/
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nuclei in Noggin−/− cultures was reduced to respectively 4% ± 2.26 and 15.8% ± 7.8 of Noggin+/+ values (Fig. 6A). 
After three days under the differentiation condition the number of MyoD+ cells was significantly reduced in 
Noggin−/− fetal myoblasts as compared to controls (8% ± 4 of Noggin+/+ cells; Fig. 6A). The myoblasts during 
the later stages of differentiation fuse to form myotubes (Suppl Fig. 1A). Thus we determined the fusion index 
calculated as the percentage of nuclei inside of MyHC+ and α -Sarcomeric Actinin+ myotubes to the number of 
total nuclei of Noggin−/− cultures and showed that it was also markedly decreased (Fig. 6A and Suppl. Fig. 1B).
To semi-quantify these observations we carried out a protein expression analysis by WB. While MyoD and 
MyHC protein levels were detectable in Noggin+/+ cells, they were almost undetectable in Noggin−/− cells at early 
(d0) and late (d3) stage of differentiation (Fig. 6B–E).
In addition, the levels of embryonic MyHC (eMyHC) strongly expressed in Noggin+/+ cells late stage, were 
barely detectable in Noggin−/− cells at both time points of differentiation (Suppl Fig. 1C).
Aberrant adipogenic potential in Noggin−/− progenitors. It has been reported that BMP signaling 
pathway is also involved in adipocyte commitment and differentiation in vitro and in vivo29,30. To investigate this 
aspect of cellular differentiation in Noggin−/− cells, we tested their adipocyte commitment in vitro by growing 
them in adipogenic medium. Noggin+/+ progenitor cells were able to shift towards an adipocyte fate, even if they 
were still able to generate myotubes (Suppl Fig. 1D). Noggin−/− cells, however, only differentiated towards adipo-
cytes, even more efficiently compared to Noggin+/+ cells (1.7 ar ± 0.2 vs. 1 ar ± 0.03) as shown by quantification 
of Oil-Red-O staining (Fig. 7A,B).
The molecular signature of these cells further supported their adipogenic phenotype. Noggin−/− cells showed 
a significant increase in the expression of the majority of the adipocyte genes after 6 days of adipogenic induction 
as shown by qRT-PCR data (Fig. 7C and Table 1- please note the logarithmic scale on the Figure). Notably, at day 
0 Perilipin (166% ± 1.5) and Adiponectin (151% ± 1.6) were already present at increased levels as compared to 
the Noggin−/− cells (Fig. 7C).
Discussion
We have previously reported on a muscle defect in Noggin−/− mice4. Here we investigated the molecular basis 
of that phenotype. Interestingly, the defect has a late onset, indicating that the initial muscle induction and for-
mation occurs normally. At the later stages however, when the muscle acquires more mass, it becomes sensitive 
to the absence of Noggin. Our analysis indicates that the loss of Noggin in the mouse embryonic muscle resulted 
in an increased BMP signaling together with a decrease in the relative number of Pax7+ cells. Intriguingly, the 
differentiation defect persisted in in vitro setting suggesting that it was cell autonomous. Specifically the cells lost 
the ability to enter the myogenic pathway while maintained the adipogenic one.
Our analysis shows that the loss of Noggin during mouse embryonic development results in an increased BMP 
signaling in developing muscle. Molecularly it has been shown that the inhibitory effect of BMP signaling on the 
myogenic program is a result of the sequestering of the E-proteins by the immediate BMP target genes (Id1, 2, 3)31,32. 
Thereby the ID proteins block the MRF-mediated activation of the myogenic program, which is dependent on 
the binding of the MRFs to these E-proteins. Furthermore, Msx1 was shown to block cellular differentiation 
by preventing cell cycle exit and to antagonize the myogenic activity of Pax3 in migrating limb muscle precur-
sors33,34. Since the BMP target genes are upregulated in the Noggin−/− mice, the sequestering of the E-proteins, 
the inhibition of cell cycle exit and/or the loss of differentiation of the migrating limb precursors are all potential 
mechanisms underlying the Noggin−/− muscle phenotype.
The BMP signaling was shown to regulate the patterning of the somite and the myogenic program3, thus a 
muscle defect in BMP antagonist mutants could have been anticipated. However, the extent of the muscle defect 
in the Noggin−/− mice and the late onset was far greater than reported for other BMP antagonist mutants35. Reshef 
et al. did suggest that the epaxial musculature in the Noggin−/− mice was largely absent in the posterior part of 
the embryo, but no further research was conducted on the muscles of the Noggin−/− mice36. The work presented 
by Lassar’s group did in fact lay a foundation for our work. Reshef et al. have shown that the precise regulation of 
BMP signaling by Noggin and other antagonists, controls the entry of Pax3+ cells into myogenic differentiation 
program defined by the expression levels of MyoD and Myf5. This regulatory loop is therefore essential for the 
myogenesis within the somites in vitro and in ovo. We have extended the work of Reshef et al. by showing that the 
same regulatory loop used also at later stages of development in mouse. Specifically, we show that, in Noggin−/− 
embryos, not only the muscle fibers exhibit a morphological defect but the maintenance of the fetal myogenic 
progenitor pool is impaired as well. In fact, we show for the first time that Noggin−/− myogenic progenitors are 
unable to properly differentiate into the myogenic lineage, but display a more efficient commitment to adipogenic 
lineage.
In vitro, BMP signaling was shown to balance the proliferation and differentiation of muscle satellite cells. 
Upon differentiation, BMP signaling is downregulated resulting in the activation of the myogenic program and 
formation of myofibers37,38. In contrast, when BMP was applied ectopically in the chicken wing, the number of 
muscle fibers and Pax7+ cells increased14,16. However, when BMP was applied during earlier stages of chicken 
development, similar chondrogenesis and myogenesis defects were seen as in the Noggin−/− mice39. These results 
strongly suggest that the timing and the localization of the BMP signal and the differentiation status of the target 
cells determines the molecular response explaining the apparent contradiction in the results published by us and 
among these research groups.
It was suggested that cells in the somitic environment could have different intrinsic properties as they respond 
differently to the same signals40. For example, embryonic myoblasts were shown to be insensitive to BMP sign-
aling allowing them to stop proliferating and differentiate into the primary myofibers. For fetal myoblasts and 
satellite cells, however, it was shown that the level of BMP signaling has to be reduced, by either reducing the 
expression of BMP ligands, or antagonizing the signaling, in order to let differentiation and fusion into secondary 
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Figure 6. Quantification of myogenic differentiation of Noggin−/− early fetal progenitors. (A) Upper 
panels: IF analysis for Pax7+ (red), Myf5+ (green) nuclei of early fetal myoblasts in growing medium (day 0 of 
differentiation) from both Noggin+/+ and Noggin−/− embryos. Nuclei were stained with HOECHST (blue). The 
quantification of Pax7+ Myf5+ cells is reported in the upper right panel. Middle panels: IF analysis for MyoD+ 
(red) in Noggin+/+ and Noggin−/− cells at day 0 of differentiation; histogram with the percentage of MyoD+ 
nuclei in Noggin−/− cells with respect to Noggin+/+ cells are reported in the middle right panel. Lower panels: 
IF analysis for MyHC+ (red) myotubes and MyoD+ (green) nuclei in cells maintained during three days in 
differentiation medium. Fusion index (FI) analysis of differentiated Noggin−/− cells compared to Noggin+/+ cells 
is shown in the right panel. Data are representative of 3 independent experiments and values are expressed as 
mean ± sd, relative to Noggin+/+; #p < 0.001 vs Noggin+/+. An inset in each panel shows DIC images of cells. 
(B) WB analysis at 0 and 3 days of differentiation for MyoD; (C) protein quantification is reported in the lower 
panel. (D) WB analysis at 0 and 3 days of differentiation for MyHC; (E) protein quantification is reported in 
the lower panel. GAPDH and tubulin (TUB) were used as loading controls in B and C respectively. Data are 
representative of 3 independent experiments and values are expressed as mean ± sd; *p < 0.05, $p < 0.01.
www.nature.com/scientificreports/
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fibers occur16. This potentially explains the Noggin−/− muscle phenotype, as the increased BMP signaling in the 
muscle would have no effect on the differentiation of the primary fibers, but it could inhibit the generation of 
the secondary fibers. Therefore fetal myoblasts, which normally give rise to the secondary fibers, maintain the 
committed but undifferentiated state. Indeed, we observe mononucleated myoblasts in the Noggin−/− muscle, 
Figure 7. Adipogenic induction of Noggin−/− early fetal progenitors. (A) Oil-Red-O staining of Noggin+/+ 
(upper panels) and Noggin−/− (lower panels) early fetal progenitors cultivated for 6 days under adipogenic 
condition; higher magnifications of the inset are reported in right panels. (B) Lipid quantification of Noggin+/+ 
and Noggin−/− cells. (C) qRT-PCR analysis of adipogenic markers at d0 and d6 of differentiation. Data of at least 
5 independent experiments are expressed as Δ Δ ct values normalized to specific housekeeping genes (Gapdh, 
Hprt and Tbp); values reported as mean ± SEM, normalized to Noggin+/+ values. *p < 0.01, #p < 0.001;  
@ p < 0.001; ∞p < 0.05, §p < 0.01, % p < 0.001.
www.nature.com/scientificreports/
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concomitant with a reduction of multinucleated myofibers. The limited number of primary fibers that is formed 
in the absence of Noggin results in a muscle that fails to maintain its organization.
Another explanation of the observed phenotype could be based on a possibility of lineage switch. In fact, the 
myogenic potential of C2C12 cells can be fully blocked by the addition of BMP ligands, which then promote 
osteochondrogenic differentiation of this cell line41,42 and reviewed in ref. 43. Thus we hypothesize that a number 
of muscle progenitor cells are drawn into the chondrogenic lineage in the Noggin−/− limb44,45. This would deplete 
the pool of muscle precursors in a way that initially enough cells are left to maintain the muscle organization, but 
at later stages, when the muscles grow rapidly, there are not enough cells to supply the muscle. In this view, the 
loss of Noggin induces SMAD-dependent increase in BMP signaling that results in an inhibition of fetal myoblast 
differentiation and a reduction in the number of satellite cells, which causes a severe late-onset muscle defect. At 
the same time, the prechondrogenic pool increases, leading to excessive chondrogenesis.
To test this hypothesis we investigated the molecular and cellular properties of mononuclear myogenic pro-
genitors isolated from Noggin+/+ and Noggin−/− littermates. Interestingly, the transcript levels of early myogenic 
markers (Pax3 and Pax7) had the same dynamics in Noggin+/+ and Noggin−/− progenitors. However, protein 
levels of Myf5 and MyoD were significantly reduced in Noggin−/− progenitors after 3 days of myogenic induction. 
Indeed, it has been previously reported that no significant differences were detected for Pax3, Pax7 and Myf5 
expression in Noggin−/− embryonic muscles13. The regulation of Pax7 protein levels is complex and not yet com-
pletely defined. In principle we cannot exclude that in our conditions, as recently reported46 and reviewed in ref. 23, 
a post-translational modification could induce the ubiquitination and consequently a cleavage of Pax7.
In this view a complete inhibition of the MyoD and possibly Myogenin proteins is probably the main cause of 
the lack in differentiation of early fetal myoblasts in our cultures as it was previously reported47.
One of the key findings of this work is that MyoD and consequently embryonic and adult MyHC protein levels 
are strongly decreased in Noggin−/− progenitors. Recently, the pattern of expression of MyHC isoforms has been 
fully characterized and defined as a transition form from one cohort of MyHC isoforms (embryonal, neonatal 
and type I MyHC) to another (fast type II isoforms), occurring during muscle cell differentiation48. Thus, eMyHC 
dramatically decreased in Noggin−/− cells at both time points considered, could not support further expression of 
the adult MyHC isoform.
Intriguingly, the response of the Noggin−/− muscle progenitors to adipocytogenic conditions dramatically dif-
fers from the wild type cells. The absence of Noggin and thus overexposure to BMP signaling during embryonic 
development induces the muscle progenitor cells to be significantly more responsive to adipogenic activation 
than the corresponding wild type cells. Indeed, Adiponectin and Perilipin genes normally expressed in adult white 
adipose tissue49, are also highly transcribed in these aberrant progenitor cells.
These results are in line with previous reports showing the participation of BMP4 in adipocyte lineage com-
mitment and the rescue induced with Noggin exposure in vivo50. Moreover, it has been recently demonstrated 
that murine myoblasts (C2C12) display lipid accumulation upon BMP6 stimulation51.
Taken together our results stress the importance of balance between Noggin and BMPs for myogenic com-
mitment of early progenitor cells during limb development. The absence of Noggin could induce a concomitant 
BMP over-signaling, likely responsible for the impaired myogenic commitment of Noggin−/− progenitors. Indeed, 
BMP2, in cooperation with SMAD1/4 and C/EBPα , can induce the expression of PPARγ 2, key transcription 
factor for adipocyte differentiation52. Our data also indicate the power of cell memory, where the level of BMP 
exposure is remembered during later differentiation stages, even in vitro, and even when the actual signal is not 
present anymore.
Further studies are necessary to define the role of other BMP inhibitors53, e.g. Chordin or Follistatin, Xnr3 or 
Cerberus, which could eventually compensate the absence of Noggin and be involved in the aberrant differenti-
ation ability observed in Noggin−/− muscle progenitors54. It could be also interesting to investigate if the altera-
tion of Noggin/BMP balance is involved in the adipogenic conversion of skeletal muscle precursors observed in 
chronic muscle degenerations.
Materials and Methods
Embryo processing. All the mouse experiments were carried out in accordance with European guidelines 
on animal research and approved by the ethics committee at the University of Leuven. Noggin heterozygous mice 
were maintained in CD1 background as described before4. Mice were sacrificed and embryos were collected at 
16.5, 17.5 and 18.5 days post coitus (dpc). Forelimbs were isolated using forceps and subsequently embedded in 
Tissue-Tek (Laborimpex), snap frozen in liquid nitrogen and stored at − 80 °C. Hind limbs were processed for 
beta-galactosidase (beta-gal) genotyping. Frozen sections (5 μ m) for immunological and histological staining 
(Haematoxylin and eosin; standard protocol) were made using a cryostat (Prosan).
Perilipin PPARg Adipo-nectin ADPR FAS aP2 cEBP LPL SREBP1
Noggin+/+ d0 1.0 ± 0.5 1.0 ± 0.3 1.0 ± 0.3 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.3 1.0 ± 0.2 1.0 ± 0.5 1.0 ± 0.1
Noggin−/− d0 16.6 ± 1.5** 1.3 ± 0.3 15.2 ± 1.6** 1.5 ± 0.3 1.1 ± 0.2 1.7 ± 0.3 2.2 ± 0.5 0.8 ± 0.2 0.9 ± 0.1
Noggin+/+ d6 15.2 × 103 ± 0.4*** 8.5 ± 0.3*** 3.2 × 103 ± 0.4*** 10.9 × 103 ± 0.3*** 29.4 ± 0.2*** 253.8 ± 0.4*** 57.4 ± 0.2*** 20.1 ± 0.2*** 5.9 ± 0.0***
Noggin−/− d6 20.7 × 10
3 ± 0.3*** 
$$ °°°
13.5 ± 0.2*** 
$ °°°
7.4 × 103 ± 0.3*** 
$ °° 17.9 ± 0.4*** °°°
38.1 ± 0.4*** 
$$$°°°
569.2 ± 0.1*** 
$ °°°
88.5 ± 0.5*** 
$$ °°°
23.9 ± 0.3*** 
°°°
8.5 ± 0.4*** 
$$$ °°°
Table 1.  ΔΔct values normalized to specific housekeeping genes of qRT-PCR analysis reported in Fig. 7C.
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Beta-galactosidase genotyping. Targeted Noggin inactivation was achieved by replacing Noggin exon 
with LacZ expression cassette3 permitting the genotyping by beta-gal staining. The well-described phenotypic 
differences were used to discriminate between heterozygous and homozygous animals (4,55). Hind limbs were 
fixed in 4% PFA in PBS for 10 minutes and washed twice with LacZ1 solution (PBS, 2mM MgCl2, 5 mM EGTA) 
for 10 minutes at RT, followed by another washing step with LacZ2 (PBS, 0.1 M Na3PO4, 2 mM MgCl2, 0.01% 
sodium deoxycholate, 0.02% NP-40; pH 7.2–7.4) for 5 minutes at RT. Staining was performed by applying staining 
solution (5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 0.5 mg/ml, X-gal in LacZ2 buffer for 2–3 hours at 37 °C or ON at 
RT. After washing steps with PBS and clearing with 2% KOH, limbs were treated with an increasing gradient of 
glycerol/KOH before storage.
Immunohistochemistry. Frozen sections were fixed with methanol for 10 minutes at − 20 °C. After quench-
ing in 3% H202/MQ and washing in TBST, antigen retrieval was performed with sodium citrate buffer (pH6), 
followed by additional washing with TBST. Sections were blocked with Normal Goat Serum (Millipore) (1/5 in 
TBST) and O/N incubated with the primary antibody (P-SMAD1/5/8, Cell Signaling, 9511S; 1/100) at 4 °C. After 
washing, the biotinylated secondary antibody was applied for 30 minutes at RT. The signal was amplified with the 
ABC reagent (Vectastain, dilution according to manufacturer’s protocol) for 30 minutes at RT. Phalloidin stain-
ing was performed using manufacturers protocol (Sigma). After washing, the color was developed using DAB 
(DAKO, dilution according to manufacturer’s protocol) and sections were mounted using Pertex.
The P-SMAD1/5/8 protocol was used with following modifications. Frozen sections were fixed with ethanol 
and methanol for 5 minutes and quenched in 0.5% H202/MeOH. Washing steps were performed with PBS, a KI67 
antibody (DAKO TEC3; 1/100) or Pax7 antibody (Hybridoma bank, Iowa, USA; 1/400) was used and blocking 
was done with 10%NGS/PBS. ImageJ software was used to measure muscle fiber thickness and the quantification 
of the percentage of P-SMAD1/5/8, KI67 or Pax7+ cells. The significance of the difference in expression was ana-
lyzed using 2way ANOVA test with Bonferroni comparison and significance was achieved with p-values less than 
0.05 (Student’s T-test).
Gene expression analysis. For muscle tissue, RNA was isolated by scraping the muscles of at least 10 fro-
zen sections 16.5 dpc embryonic limbs using the High Pure RNA Isolation Kit (Roche Applied Science). At least 
three RNA isolations were performed per condition and subsequently reverse transcribed using Primescript 
RT Reagent (Takara; manufacturers protocol). qRT-PCR was performed in duplicate with gene specific primers 
(Table 2) with SYBR Premix Ex Taq II (Takara; manufacturers protocol) using Rotor-gene 6000 detection system 
(Corbett Research, Westburg). Gene expression was normalized to the housekeeping gene Hprt1 and presented as 
a ratio to control embryos. The significance of the difference in expression was analyzed using the Student’s T-test.
For the cells, Noggin+/+ and Noggin−/− early fetal myoblasts, chondrocytes and fibroblasts were used for RNA 
extraction with RNA Mini Kit, removing genomic DNA traces by Turbo DNase. 1ug RNA was reverse-transcribed 
with SuperScript III kit and qPCR was performed in 384 well plates (10ul final volume; thermal profile, 95 °C 15″ 
− 60 °C 45″ (40x); ViiA 7 qPCR plate reader), using Platinum Sybr Green Mix, 1ul 1:4 diluted cDNA and 250 nM 
primers (all kits, reagents and plate reader by Life Technologies, Carlsbad, CA, USA). Proliferating MEF cells as 
well as fibroblasts from adult mice or 3T3-L1 preadipocytes (ATCC, Manassas, VA, USA) were used as positive 
controls.
Fetal myoblasts isolation and myogenic differentiation. Early fetal myoblasts were isolated from 
forelimbs of E16.5 Noggin−/− and control embryos (after careful removal of bones and skin) as previously 
described40. Briefly, tissues were dissociated one hour at 37 °C with 0.06% Collagenase (from Clostridium 
Histolyticum, Sigma-Aldrich St. Louis, Mo, USA, for all reagents excepted when notified) and 0.04% Pancreatin 
in PBS (Gibco-Invitrogen, Carlsbad, CA, USA). After centrifugation, cells were seeded in collagen-coated 
dishes in presence of Dulbecco’s modified Eagle’s medium (DMEM)-high glucose and 20% fetal bovine serum 
(FBS; Gibco-Life Technologies, Carlsbad, CA, USA), supplemented with 1% Chicken Embryo Extract (Sera 
Laboratories International, UK), 100 mg/ml Sodium Pyruvate, 100 IU/ml penicillin and streptomycin, 2 mM 
L-glutamine. The plates were incubated at 37 °C, 5% CO2, 5% O2 and the medium refreshed every two days. 
When cells reached confluence, the differentiation was induced by shifting medium to DMEM high glucose 
supplemented with 2% horse serum (Gibco-Invitrogen, Carlsbad, CA, USA) and 100 mg/ml Sodium Pyruvate 
(differentiation medium; DM).
Adipogenic differentiation. Early fetal myoblasts were dispended on collagen coated dishes and expanded 
till confluence, in presence of STEMPRO Adipogenesis Differentiation Medium (Gibco-Lyfe Technologies, 
Carlsbad, CA, USA) to enhance adipogenesis, as described from the manufacturer. 3T3-L1 preadipocytes 
(ATCC) used as control for adipocyte differetiation were grown in DMEM supplemented with 10% (v/v) fetal 
calf serum (Gibco-Lyfe Technologies, Carlsbad, CA, USA), 25 mM HEPES (pH 7.0), 100 U/ml penicillin and 
streptomycin, and 25 μ g/ml Fungizone Antimycotic (Gibco-Lyfe Technologies, Carlsbad, CA, USA). To induce 
adipocyte differentiation, confluent cells were cultured in DMEM with 10% (v/v) FBS (Gibco-Lyfe Technologies, 
Carlsbad, CA, USA), 25 mM HEPES (pH 7.0), 100 U/ml penicillin and streptomycin, and 25 μ g/ml fungizone, 
plus 0.5 mM isobutylmethyl-xanthine, 1 μ M dexamethasone, and 1 μ g/ml insulin (MDI). MDI was replaced 48 h 
after, with insulin (1 μ g/ml), and the medium changed every two days.
Immunofluorescence analysis. Cells at day 0 and 3 of differentiation were fixed with 4% PFA (Polysciences 
Europe GmbH, Germany) and permeabilized with 0.2% PBS-Triton, 1% Bovine Serum Albumin (BSA). A 
blocking solution containing donkey serum was applied and primary antibodies were incubated overnight 
(O/N) in PBS supplemented with 2.5% w/v BSA. Primary antibodies: 1:50 anti-rabbit Myf5 (c-20, Santa-Cruz 
Byotechnology, Heidelberg, Germany), 1:3 mouse anti-PAX7 (Developmental Studies Hybridoma Bank, DSHB, 
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Iowa, USA), 1:50 mouse anti-MyoD (Dako, Agilent Technologies, Denmark), 1:30 rabbit anti-MyoD (Santa Cruz 
Byotechnology, Heidelberg, Germany), 1:10 mouse anti-MyHC (clone MF20, Developmental Studies Hybridoma 
Bank, DSHB, Iowa, USA), anti-mouse α -Sarcomeric Actinin (Abcam, Cambridge, UK). Secondary Alexa Fluor 
donkey antibodies (Life Technologies, Carlsbad, CA, USA) were diluted at 4 μ g/ml in PBS supplemented with 
2.5% w/v BSA and the nuclei counterstained with 10 ug/ml Hoechst. Fluorescence images were acquired at 10x 
magnification via Eclipse Ti inverted microscope (Nikon). Fusion index (number of myotube nuclei vs total num-
ber of nuclei) such as the percentage of myotube positive for a specific marker were calculated for a minimum of 
four random fields from Noggin+/+ and Noggin−/− embryo cells of different embryos (n = 7, three different litters).
Western blot (WB) analysis. WB analysis were performed on cell lysates in RIPA buffer supplemented 
with 10 mM Sodium Fluoride, 0.5 mM Sodium Orthovanadate, 1:100 Protease Inhibitor Cocktail and 1 mM 
Phenylmethanesulfonyl Fluoride. Equal amounts of protein (30 μ g) were heat-denatured in sample-loading buffer 
(50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromophenol blue, 10% glycerol), resolved by SDS-PAGE 
and transferred to nitrocellulose membranes (GE Healthcare Bio-Sciences, Pittsburg, USA). The filters were 
blocked with Tris-buffered saline (TBS) containing 0.05% Tween and 5% non-fat dry milk and then incubated 
overnight with the different primary antibodies: rabbit 1:1000 anti-P-SMAD1/5/8 (Cell Signaling); rabbit 1:100 
anti-SMAD1/5/8 (ThermoScientific); rabbit 1:100 anti-IDs (SantaCruz); rabbit 1:100 anti-P-ERK (SantaCruz); 
mouse 1:200 anti-ERK (SantCruz); mouse 1:100 anti-MyoD (Dako, Agilent Technologies, Denmark); mouse 1:10 
anti-MyHC and mouse 1:5 anti-eMyHC (Developmental Studies Hybridoma Bank, DSHB, Iowa, USA), mouse 
1:1000 anti-Tubulin beta, clone KMX-1 (Millipore, Chemicon, Billerica, MA, USA), anti-rabbit GAPDH. All sec-
ondary horseradish peroxidase (HRP)-conjugated antibodies (Santa Cruz Biotechnology, CA, USA) were diluted 
1:5000 in TBS-Tween and 2.5% non-fat dry milk. After incubation with SuperSignal Dura Chemiluminescence 
substrate (Thermo Scientific, Waltham, MA USA), WB analysis was performed with GelDoc chemiluminescence 
detection system (BioRad, Temse, Belgium). Quantification by relative densitometry was obtained normalizing 
versus background and GAPDH or Tubulin, using the QuantityOne software (BioRad).
Oil-Red-O staining. Lipid accumulation in early fetal myoblasts was assessed by Oil-Red-O staining. 
Briefly, cells were fixed for 15 min in 4% PFA, washed three times in PBS, and stained for 30 min with the 
lipophilic dye Oil-Red-O in 65% isopropanol, followed by washing steps and drying. Bright field Oil-Red-O 
images were captured at 10x and 20x magnification using an Eclipse Ti inverted microscope (Nikon). Lipids 





























Thy 168 GCCGCCATGAGAATAACA GCTAGGGTAAGGACCTTGAT
Table 2.  list of primers.
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extracted with a petrol ether/isopropanol mixture (3:2) were quantified for their absorbance at 490 nm with 
Victor spectrophotometer (PerkinElmer, Massachussets, USA).
Statistical analysis. All results were expressed as mean ± SD, with the exception of gene expression 
(mean ± SEM). Representative WB show independent samples. When two groups were compared, a Student’s 
t-test was used. When three or more groups were compared a two-way ANOVA was used. The statistical sig-
nificance of the differences between percentage values was assessed using a Kruskal-Wallis one-way analysis of 
variance by ranks test. All statistical tests were performed via Prism software (GraphPad).
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